Curcumin nanoparticles and the therapeutic potential of curcumin for musculoskeletal disorders
H.-Y. Wu, H.-T. Yu, B. Kang, Y.-Y. Xuan, H.-Q. Zhang, X.-S. Li Department of Joint Surgery, The 940th Hospital of Joint Logistics Support Force of The Chinese People’s Liberation Army, Lanzhou, Gansu, China. zhanghaoqiang_fmmu@163.com
Musculoskeletal disorders (MSD) are a collection of degenerative conditions impacting the body’s bones, joints, muscles, tendons, ligaments, and nerves. MSDs affect approximately 1.71 billion individuals worldwide and are a significant cause of disability. Curcumin is a polyphenolic compound with anti-inflammatory, antioxidant, and antitumor properties. In this review, we will discuss the research progress of structural analogs, derivatives, and nanomaterials that can improve the bioavailability of this natural drug. Curcumin may potentially retard the progression of osteoporosis, osteoarthritis, and rheumatoid arthritis. These effects may be related to curcumin’s targeting of multiple signalling pathways.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
H.-Y. Wu, H.-T. Yu, B. Kang, Y.-Y. Xuan, H.-Q. Zhang, X.-S. Li
Curcumin nanoparticles and the therapeutic potential of curcumin for musculoskeletal disorders
Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 20
Pages: 9680-9702
DOI: 10.26355/eurrev_202310_34139